Increasing Incidence of Cancer Fueling Worldwide Demand for Cancer/Tumor Profiling

With the surge in the number of cancer cases every year, the demand for cancer/tumor profiling is growing rapidly across the world. Several factors such as changing lifestyles, increasing tobacco consumption, high exposure to radiation, and poor eating habits are fueling the incidence of cancer all over the world. For instance, the American Cancer Society stated in 2017 that the country witnessed nearly 1,688,780 new cases of cancer in that year. 

Moreover, the organization predicted around 600,920 Americans will die because of cancer and the country will witness a cancer mortality rate of 1,650 persons per day from 2017 to 2023. Besides this, the growing requirement for the next generation sequencing (NGS) technology for tumor profiling is also pushing up the demand for cancer/tumor profiling around the world. Many cancer profiling organizations are developing tumor profiling kits with the help of the NGS technology.

For example, biomarkers based on the NGS, in-situ hybridization (ISH), and immunohistochemistry (IHC) technologies were developed by Caris Life Sciences for identifying protein expression levels and fusions and translocations, analyzing gene amplifications and deletion, and the broad detection and rapid examination of DNA mutation. Due to these factors, the demand for cancer/tumor profiling is surging sharply across the world. This is, in turn, driving the progress of the global cancer/tumor profiling market.

Geographically, the demand for tumor profiling will soar in Asia-Pacific (APAC) in the coming years, as per the estimates of P&S Intelligence, a market research company based in India. This will be because of the growing incidence of cancer, the surging healthcare expenditure, and the increasing implementation of various government initiatives and policies for cancer treatment in the region. As per the Indian Council of Medical Research (ICMR), over 1.4 million cancer cases were reported in India in 2016.

Hence, it is safe to say that the demand for cancer/tumor profiling will shoot up across the world in the coming years, primarily because of the rising incidence of cancer, the surging healthcare expenditure, and the mushrooming requirement for advanced cancer detecting methods in various countries.